Trulicity Injection

Dulaglutide
1.5mg/Pen
ELI LILLY AND COMPANY
Pack size 4 Pre-filled Pen
Dispensing mode POM
Source USA
AgentPHARMATRADE
Retail Price 957.00 AED

Indications

Trulicity Injection is used for: Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Dulaglutide :

Mechanism of Action

Dulaglutide is a human GLP-1 receptor agonist with 90% amino acid sequence homology to endogenous human GLP-1 (7-37). Dulaglutide activates the GLP-1 receptor, a membrane-bound cell-surface receptor coupled to adenylyl cyclase in pancreatic beta cells. Dulaglutide increases intracellular cyclic AMP (cAMP) in beta cells leading to glucose-dependent insulin release. Dulaglutide also decreases glucagon secretion and slows gastric emptying.

Note

Trulicity 1.5mg/Pen Injection manufactured by ELI LILLY AND COMPANY. Its generic name is Dulaglutide. Trulicity is availble in United Arab Emirates. Farmaco UAE drug index information on Trulicity Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Dulaglutide :